Clinical trials: Contraceptive Device; Intrauterine
Intra-uterine Device Complication
Efficacy and Safety of Different Doses of Vaginal Misoprostol Prior to Intra Uterine Contraceptive Device Insertion
investigators aim through this study to evaluate and compare the Safety and efficacy of different doses of misoprostol prior to IUCD insertion among women with nulliparous cervix beside the rate of occurrence of adverse effects.
- Trial name
- NCT04273984
- Testing
- Misoprostol
- Where
- 2 sites in Egypt
- Volunteers
- 180 people
- Sponsor
- Ain Shams University
Contraception, Reproductive Behavior
Patient-centered Information on Permanent Contraception
The goal of this study is to understand whether providing information to women with a strong desire to avoid future pregnancy about how tubal sterilization compares to long-acting reversible contraceptives improves perceived…
- Conditions
- Contraception, Reproductive Behavior, Contraception Behavior
- Trial name
- NCT06296797
- Testing
- Control arm: Existing educational website, Advancing Access Website
- Where
- United States
- Volunteers
- 650 people, healthy volunteers welcome
- Sponsor
- University of California, San Francisco
Contraception
Immediate Postpartum Insertion of Contraceptive Intrauterine Devices
In this randomized trial, investigators intend to determine the expulsion and discontinuation rate of immediate postpartum intrauterine devices in the patient population of the University of Oklahoma Women's Healthcare…
- Trial name
- NCT03657602
- Testing
- Kyleena Intrauterine System, Mirena Intrauterine System
- Where
- United States
- Volunteers
- 28 people, healthy volunteers welcome
- Sponsor
- University of Oklahoma
Contraception
Physician Self Disclosure of IUC Use
As many as one-third of female healthcare providers use intrauterine contraception (IUC), but only about 8 percent of US women overall do.
- Trial name
- NCT01994356
- Testing
- Physician self-disclosure of personal IUC use, Usual contraceptive counseling
- Where
- United States
- Volunteers
- 132 people
- Sponsor
- University of Michigan
Contraception
LCS12 Adolescent Study
The study will assess the safety of a sex hormone (levonorgestrel) releasing T-shaped intrauterine contraceptive system in female adolescents under 18 years of age.
- Trial name
- NCT01434160
- Testing
- Skyla (Levonorgestrel, BAY86-5028)
- Where
- 41 sites in Austria, Belgium and 6 more
- Volunteers
- 304 people, healthy volunteers welcome
- Sponsor
- Bayer
Contraceptive Device; Complications
Vaginal Misoprostol Before IUD Insertion in Women With Cesarean Scar
Groups of study: 120 candidates for Cu T 380A IUD insertion were enrolled in the study. They were divided into two groups: Group 1: Sixty women received 600 micrograms of misoprostol vaginally as deep as possible six hours before…
- Trial name
- NCT03081442
- Testing
- Misoprostol, Intrauterine contraceptive device IUCD
- Where
- Egypt
- Volunteers
- 120 people, healthy volunteers welcome
- Sponsor
- Cairo University
Contraception
The Effect of Ibuprofen on Intrauterine Contraceptive Device Associated Uterine Bleeding
The Copper intrauterine device is the most common method of reversible contraception worldwide. Abnormal uterine bleeding and pain are the most common medical indications for the discontinuation of the intrauterine device.
- Trial name
- NCT02580344
- Testing
- Ibuprofen
- Where
- Egypt
- Volunteers
- 128 people
- Sponsor
- Assiut University
Pain Prior to IUD Insertion
Misoprostol Prior to Intrauterine Contraceptive Device Insertion
Intrauterine devices (IUDs) are widely used as reversible contraceptives. Both copper- and levonorgestrel (LNG)-releasing IUDs (LNG-IUDs) are safe,cost-effective in the long term and equally effective compared with tubal…
- Trial name
- NCT02412033
- Testing
- Misoprostol
- Volunteers
- 140 people
- Sponsor
- Assiut University
Anemia
Levonorgestrel Intrauterine System Effects on Hemoglobin and Serum Ferritin Among Anemic Women in Kenya
Women with mild/moderate anemia who are seeking contraception will be randomized to a levonorgestrel (LNG) intrauterine system (IUS) or an LNG/ethinyl estradiol (EE)/ferrous fumarate combined oral contraceptive (COC) regimen and…
- Trial name
- LISA (NCT05233956)
- Testing
- LNG IUS, COCs
- Where
- Kenya
- Volunteers
- 405 people, healthy volunteers welcome
- Sponsor
- FHI 360
Intrauterine Contraceptive Device Complication
Intra-cesarean Post Placental Introducer Withdrawal IUD Insertion Technique
This is a prospective randomized controlled study that was conducted to compare between the conventional (manual) technique of post placental IUD insertion and a new technique (intra-cesarean post placental introducer withdrawal…
- Trial name
- IUD (NCT05788354)
- Testing
- IUD insertion during cesarean section
- Where
- 2 sites in Egypt
- Volunteers
- 788 people, healthy volunteers welcome
- Sponsor
- Cairo University
Contraception
Levonorgestrel-Intrauterine System (LNG-IUS) Insertion in the Postpartum Period
The investigators study is a prospective randomized trial of women undergoing the levonorgestrel intrauterine system (LNG-IUS: Mirena©, Bayer) at three separate time periods: immediate post placental (IPP) defined as insertion…
- Trial name
- NCT01088178
- Testing
- Levonorgestrel Intrauterine System (LNG-IUS: Mirena, Bayer)
- Where
- United States
- Sponsor
- United States Naval Medical Center, Portsmouth
Contraception
Dose-finding Study for the Ultralow-dose Levonorgestrel Intrauterine Contraceptive System (LCS)
The purpose of this study is to investigate if drug doses lower than the one released from Mirena® would be as effective for contraception as Mirena®.
- Trial name
- NCT00185380
- Testing
- Levonorgestrel IUS (BAY86-5028, G04209B), Levonorgestrel IUS (BAY86-5028, G04209C), Levonorgestrel IUS (Mirena, BAY86-5028)
- Where
- 35 sites in Finland, Hungary and 3 more
- Volunteers
- 742 people
- Sponsor
- Bayer
Adenomyosis
Levonorgestrel-releasing Intrauterine System Versus a Low-dose Combined Oral Contraceptive for Management of Adenomyosis Uteri
This study aims to compare the efficacy of LNG - IUD (Levonorgestrel releasing intrauterine device) Versus Low dose COCs (combined oral contraceptive pills) on management of heavy menstrual bleeding and Dysmenorrhea caused by…
- Trial name
- LNG-IUDvsCOCs (NCT03037944)
- Testing
- Yasmin, Metraplant-E
- Where
- Egypt
- Volunteers
- 32 people
- Sponsor
- Ain Shams Maternity Hospital
Copper Intrauterine Device Induced Bleeding
Study About Patients Using Copper Intrauterine Device
THE AIM OF THE this study is to assess the hemodynamic changes of uterine artery in patients with CIUD induced bleeding by using transvaginal color Doppler indices (uterine artery resistance index and pulsatility index) to prove…
- Trial name
- IUD (NCT01541241)
- Where
- Egypt
- Volunteers
- 100 people, healthy volunteers welcome
- Sponsor
- Egymedicalpedia
HIV Infections
Effect of an Intrauterine Contraceptive Device (IUD) in HIV Infected Women
Oral contraceptives (OCs) are not a good option for some HIV infected women because of the potential for drug interactions between OCs and anti-HIV drugs; additionally, OCs may increase the risk of transmitting HIV to sexual…
- Trial name
- NCT00096694
- Testing
- Levonorgestrel-releasing intrauterine device (IUD)
- Where
- 9 sites in United States, Puerto Rico
- Volunteers
- 41 people
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
Women at Risk for Pregnancy
A PK Study Comparing VeraCept vs. ParaGard Intrauterine Devices (IUDs)
to Assess the Pharmacokinetic Properties of VeraCept® Intrauterine Contraceptive vs ParaGard® in Healthy, Post- Menarcheal Women
- Trial name
- IUD (NCT03785366)
- Testing
- VeraCept, ParaGard
- Where
- 2 sites in United States
- Volunteers
- 41 people, healthy volunteers welcome
- Sponsor
- Sebela Women's Health Inc.
Contraception
A Pilot Study of Early Expulsion Rates of the IUB™ SCu380A
The IUB (Intrauterine ball) is a copper releasing intrauterine contraceptive device consisting of copper beads on a flexible NiTinol wire.
- Trial name
- IUB (NCT01973777)
- Testing
- IUB
- Where
- Canada
- Volunteers
- 51 people, healthy volunteers welcome
- Sponsor
- Wiebe, Ellen, M.D.
Scar Niche, Myometrial Remodeling
Postplacental Copper Intrauterine Device Versus Postpartum Progesterone-only Pills on Uterine Niche Formation
The purpose of the study is to determine whether immediate postplacental copper T380A intrauterine device insertion increases uterine-niche incidence compared with postpartum progestin-only pills after primary cesarean section .
- Conditions
- Scar Niche, Myometrial Remodeling, Contraceptive Device; Complications, Cesarean Section Complications
- Trial name
- T380A (NCT07264933)
- Testing
- Primary Cesarean Section, immediate postplacental insertion of a copper T380A intrauterine device, progesterone-only pills
- Where
- Egypt
- Volunteers
- 750 people
- Sponsor
- Benha University
Pregnancy
Better Contraceptive Choices: Immediate or Delayed Insertion of IUC After Second Trimester Abortion
Hypothesis Intrauterine contraception placed immediately after a second trimester abortion will result in fewer pregnancies than current standard practice of intended placement at 4 weeks post-abortion.
- Trial name
- NCT00877344
- Testing
- Immediate insertion, Interval insertion
- Where
- 3 sites in Canada
- Volunteers
- 474 people, healthy volunteers welcome
- Sponsor
- University of British Columbia
Contraception
A Study to Evaluate the Safety and Initial Efficacy of a Novel Intrauterine Device
Current intrauterine devices (IUD) pose such risks as uterine perforation during insertion, malposition and expulsion. The investigated device, the IUB(tm) SCu300A is an IUD which is inserted in a similar fashion into the uterus…
- Trial name
- NCT01590563
- Testing
- IUD
- Where
- Hungary
- Volunteers
- 15 people, healthy volunteers welcome
- Sponsor
- Ocon Medical Ltd.